In this 60-minute webinar, Dr. Ruslan Dorfman, Founder, CSO and CTO, and Richard Lavoie, Senior Health Economist at Geneyouin Inc. will discuss how new developments can improve the way in which employees can manage their health needs and reduce benefit costs to employers.
During this session you will:
- Learn how new developments in personalized medicine can improve health issues such as chronic conditions or pain, mental health, and heart disease, all while reducing benefit costs;
- Hear results from a recent study from the community pharmacy setting;
- Hear how genetic technology continues to evolve and become more affordable and how it can benefit employers and employees.
Dr. Ruslan Dorfman is Founder, CSO and CTO of GeneYouIn Inc, a Canadian genomic health IT provider of PillCheck Medication Optimization Service. Dr. Dorfman is a molecular geneticist by training; he is passionate about pharmacogenetics of chronic pain and genetics of rare diseases. Prior to founding GeneYouIn in 2012 he worked at Sick Kids Hospital, and developed Personalized Medicine Strategy at the Mount Sinai Hospital. Dr. Dorfman published more than 30 manuscripts on genetics of Cystic Fibrosis, disease modifying genes, and pain genetics.Dr. Dorfman has expertise in clinical study design, statistical analysis, pharmacogenetics, genomic annotation and healthcare strategy.
Richard Lavoie is a senior economist with over 15 years of experience as an expert economic consultant in the healthcare industry. He has managed consultants serving pharmaceutical firms, insurers and governments and conducting pharmacoeconomic projects, data analysis, market assessments and strategic initiatives. He currently acts as an independent health economics expert for his pharmaceutical and insurance clients. He has developed the analytical skills and his in-depth understanding of market dynamics to integrate various sources of information and generate the insights needed for decision-making. Richard Lavoie holds a masters in applied economics (HEC Montréal).